Kobe, Japan

Daisuke Yokoyama

This inventor holds 1 USPTO granted patent. Top assignee: Sysmex Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daisuke Yokoyama. Retrieved from https://idiyas.com/inventor/daisuke-yokoyama-wxba1d8y

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Daisuke Yokoyama: Innovator in Hemolytic Reagents

Introduction

Daisuke Yokoyama is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of medical reagents, particularly in the classification of white blood cells. His innovative work has led to the development of a unique hemolytic reagent.

Latest Patents

Daisuke Yokoyama holds 1 patent for his invention titled "Hemolytic reagent, reagent kit, and method for classifying white blood cells." This patent discloses a hemolytic reagent that comprises a nonionic surfactant represented by a specific formula. This invention plays a crucial role in enhancing the accuracy of white blood cell classification.

Career Highlights

Daisuke Yokoyama is currently employed at Sysmex Corporation, a leading company in the field of medical diagnostics. His work at Sysmex has allowed him to focus on developing innovative solutions that improve healthcare outcomes. His expertise in reagent development has positioned him as a valuable asset to the company.

Collaborations

Daisuke has collaborated with notable colleagues, including Takanori Komaki and Masaki Abe. These collaborations have fostered a creative environment that encourages innovation and the advancement of medical technologies.

Conclusion

Daisuke Yokoyama's contributions to the field of hemolytic reagents exemplify the impact of innovation in medical diagnostics. His work continues to influence the classification of white blood cells, showcasing the importance of research and development in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…